Kingdon Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-158,382
Closed -$8.96M – 78
2022
Q1
$8.96M Buy
+158,382
New +$8.27M 0.93% 27
2015
Q4
– Sell
-307,714
Closed -$9.39M – 122
2015
Q3
$9.39M Sell
307,714
-80,950
-21% -$2.82M 0.45% 57
2015
Q2
$14.2M Buy
388,664
+85,476
+28% +$3.05M 0.56% 60
2015
Q1
$10.7M Buy
303,188
+26,648
+10% +$912K 0.45% 65
2014
Q4
$8.46M Buy
+276,540
New +$8.62M 0.37% 78
2013
Q4
– Sell
-167,055
Closed -$4.58M – 190
2013
Q3
$4.58M Sell
167,055
-31,425
-16% -$807K 0.23% 127
2013
Q2
$4.55M Buy
+198,480
New +$4.49M 0.27% 107

Other funds holding EHC

Kingdon Capital Management's EHC Position: Q2 2022 in Review

Kingdon Capital Management sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 158,382 shares — an estimated $8.96M sold.

Kingdon Capital Management first reported a position in EHC in Q2 2013 and held it in 7 quarters. The position peaked at $14.2M in Q2 2015. 394 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

  • Kingdon Capital Management reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
  • Kingdon Capital Management sold 158,382 Encompass Health shares in Q2 2022, an estimated $8.96M.
  • Kingdon Capital Management first reported a position in Encompass Health in Q2 2013 and held it in 7 quarters.
  • Kingdon Capital Management's Encompass Health position peaked at $14.2M in Q2 2015.
  • 394 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Kingdon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.